Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-25-000051
Filing Date
2025-10-30
Accepted
2025-10-29 18:09:46
Documents
109
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20250930.htm   iXBRL 10-Q 2693275
2 EX-31.1 exhibit311q32025.htm EX-31.1 9973
3 EX-31.2 exhibit312q32025.htm EX-31.2 9889
4 EX-32.1 exhibit321q32025.htm EX-32.1 6495
5 EX-32.2 exhibit322q32025.htm EX-32.2 6433
  Complete submission text file 0000885590-25-000051.txt   13482817

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20250930.xsd EX-101.SCH 96929
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20250930_cal.xml EX-101.CAL 91220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20250930_def.xml EX-101.DEF 561153
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20250930_lab.xml EX-101.LAB 979589
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20250930_pre.xml EX-101.PRE 788146
111 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20250930_htm.xml XML 2271139
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 251431442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)